Study to Evaluate if Inhaled Nitric Oxide Improves Liver Function After Transplantation

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Reperfusion Injury, Liver Injury

In brief

This blinded, placebo-controlled study will administer inhaled nitric oxide to patients undergoing liver transplantation. The purpose of the study is to test if inhaled nitric oxide prevents liver injury associated with the restoration of blood flow. The premise of the current study is provided by previous studies which document a protective effect of inhaled nitric oxide in this clinical setting.

Key facts

Study ID

NCT00582010

Run by

University of Alabama at Birmingham

People needed

80

Starts

2008-04-01

Expected to finish

2012-10-01

Last updated by the study team

2014-11-06

Who can join

Age: 19 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients > 19 yr of age scheduled to undergo liver transplantation.

You may not qualify if…

• Patients < 19 yr of age
• Patients undergoing re-transplantation or dual organ transplantation
• Patients with underlying pulmonary complications

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States
• University of Washington — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.